Visilizumab

Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Template:Drugbox-mab Visilizumab (marketed under the trade name Nuvion by PDL BioPharma Inc.) is a humanized monoclonal antibody. It is being investigated for use as an immunosuppressive drug in patients with ulcerative colitis and Crohn disease. Visilizumab binds to the CD3 receptor on certain activated T cells without effecting resting T cells.

External link

Template:Immunosuppressants Template:Humanizedmonoclonals Template:WikiDoc Sources